FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4324306066> ?p ?o ?g. }

• W4324306066 endingPage "479" @default.
• W4324306066 startingPage "455" @default.
• W4324306066 abstract "Cancer-associated fibroblasts (CAFs) play an important role in the induction of chemo-resistance. This study aimed to clarify the mechanism underlying CAF-mediated resistance to two tyrosine kinase inhibitors (TKIs), sorafenib and lenvatinib, and to identify a novel therapeutic target for overcoming TKI resistance in hepatocellular carcinoma (HCC).We performed a systematic integrative analysis of publicly available gene expression datasets and whole-transcriptome sequencing data from 9 pairs of CAFs and para-cancer fibroblasts isolated from human HCC and para-tumor tissues, respectively, to identify key molecules that might induce resistance to TKIs. We then performed in vitro and in vivo experiments to validate selected targets and related mechanisms. The associations of plasma secreted phosphoprotein 1 (SPP1) expression levels before sorafenib/lenvatinib treatment with progression-free survival (PFS) and overall survival (OS) of 54 patients with advanced HCC were evaluated using Kaplan-Meier and Cox regression analysis.Bioinformatic analysis identified CAF-derived SPP1 as a candidate molecule driving TKI resistance. SPP1 inhibitors reversed CAF-induced TKI resistance in vitro and in vivo. CAF-derived SPP1 activated rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) through the integrin-protein kinase C-alpha (PKCα) signaling pathway and promoted epithelial-to-mesenchymal transition (EMT). A high plasma SPP1 level before TKI treatment was identified as an independent predictor of poor PFS (P = 0.026) and OS (P = 0.047) in patients with advanced HCC after TKI treatment.CAF-derived SPP1 enhances TKI resistance in HCC via bypass activation of oncogenic signals and EMT promotion. Its inhibition represents a promising therapeutic strategy against TKI resistance in HCC. Moreover, plasma SPP1 level before TKI treatment represents a potential biomarker for treatment response prediction." @default.
• W4324306066 created "2023-03-16" @default.
• W4324306066 creator A5002802312 @default.
• W4324306066 creator A5018024499 @default.
• W4324306066 creator A5020409600 @default.
• W4324306066 creator A5022013789 @default.
• W4324306066 creator A5023952106 @default.
• W4324306066 creator A5028627485 @default.
• W4324306066 creator A5031215301 @default.
• W4324306066 creator A5048222855 @default.
• W4324306066 creator A5051464296 @default.
• W4324306066 creator A5060079879 @default.
• W4324306066 creator A5064707258 @default.
• W4324306066 creator A5066087576 @default.
• W4324306066 creator A5074812947 @default.
• W4324306066 creator A5079274855 @default.
• W4324306066 creator A5086098946 @default.
• W4324306066 date "2023-03-14" @default.
• W4324306066 modified "2023-10-18" @default.
• W4324306066 title "Cancer‐associated fibroblast‐derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinib" @default.
• W4324306066 cites W1557808229 @default.
• W4324306066 cites W1777535941 @default.
• W4324306066 cites W1971837077 @default.
• W4324306066 cites W1972162901 @default.
• W4324306066 cites W1977630546 @default.
• W4324306066 cites W1993690997 @default.
• W4324306066 cites W1994193851 @default.
• W4324306066 cites W2007129479 @default.
• W4324306066 cites W2033985429 @default.
• W4324306066 cites W2058522541 @default.
• W4324306066 cites W2096488601 @default.
• W4324306066 cites W2117646020 @default.
• W4324306066 cites W2123242217 @default.
• W4324306066 cites W2124706864 @default.
• W4324306066 cites W2132378346 @default.
• W4324306066 cites W2155450435 @default.
• W4324306066 cites W2277004004 @default.
• W4324306066 cites W2309086988 @default.
• W4324306066 cites W2319133637 @default.
• W4324306066 cites W2611921638 @default.
• W4324306066 cites W2787358630 @default.
• W4324306066 cites W2790339676 @default.
• W4324306066 cites W2796067155 @default.
• W4324306066 cites W2802511149 @default.
• W4324306066 cites W2802764635 @default.
• W4324306066 cites W2807815694 @default.
• W4324306066 cites W2885162827 @default.
• W4324306066 cites W2912124024 @default.
• W4324306066 cites W2912451416 @default.
• W4324306066 cites W2932807328 @default.
• W4324306066 cites W2941384888 @default.
• W4324306066 cites W2943005115 @default.
• W4324306066 cites W2949512677 @default.
• W4324306066 cites W2964966581 @default.
• W4324306066 cites W2969802526 @default.
• W4324306066 cites W2980925374 @default.
• W4324306066 cites W2998980069 @default.
• W4324306066 cites W2999298357 @default.
• W4324306066 cites W3005975331 @default.
• W4324306066 cites W3012731546 @default.
• W4324306066 cites W3026099517 @default.
• W4324306066 cites W3041798570 @default.
• W4324306066 cites W3085416127 @default.
• W4324306066 cites W3106035297 @default.
• W4324306066 cites W3112963314 @default.
• W4324306066 cites W3132004661 @default.
• W4324306066 cites W3137570767 @default.
• W4324306066 cites W3195264720 @default.
• W4324306066 cites W4232539975 @default.
• W4324306066 cites W4324306066 @default.
• W4324306066 doi "https://doi.org/10.1002/cac2.12414" @default.
• W4324306066 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36919193" @default.
• W4324306066 hasPublicationYear "2023" @default.
• W4324306066 type Work @default.
• W4324306066 citedByCount "11" @default.
• W4324306066 countsByYear W43243060662023 @default.
• W4324306066 crossrefType "journal-article" @default.
• W4324306066 hasAuthorship W4324306066A5002802312 @default.
• W4324306066 hasAuthorship W4324306066A5018024499 @default.
• W4324306066 hasAuthorship W4324306066A5020409600 @default.
• W4324306066 hasAuthorship W4324306066A5022013789 @default.
• W4324306066 hasAuthorship W4324306066A5023952106 @default.
• W4324306066 hasAuthorship W4324306066A5028627485 @default.
• W4324306066 hasAuthorship W4324306066A5031215301 @default.
• W4324306066 hasAuthorship W4324306066A5048222855 @default.
• W4324306066 hasAuthorship W4324306066A5051464296 @default.
• W4324306066 hasAuthorship W4324306066A5060079879 @default.
• W4324306066 hasAuthorship W4324306066A5064707258 @default.
• W4324306066 hasAuthorship W4324306066A5066087576 @default.
• W4324306066 hasAuthorship W4324306066A5074812947 @default.
• W4324306066 hasAuthorship W4324306066A5079274855 @default.
• W4324306066 hasAuthorship W4324306066A5086098946 @default.
• W4324306066 hasBestOaLocation W43243060661 @default.
• W4324306066 hasConcept C121608353 @default.
• W4324306066 hasConcept C126322002 @default.
• W4324306066 hasConcept C184235292 @default.
• W4324306066 hasConcept C2776264508 @default.
• W4324306066 hasConcept C2778019345 @default.

• next